Replies to post #427307 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The benefit of sticking with original trial design is that DCVax-L would have been available years earlier which is good for long term investors and patients alike.

Instead we just get delay piled on delay and the patient body count rises.

[lrdpdx77]

Great post and reply.